{
    "clinical_study": {
        "@rank": "156216", 
        "acronym": "RACE", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Normal saline"
            }, 
            {
                "arm_group_label": "Carnitine Low", 
                "arm_group_type": "Experimental", 
                "description": "Levo-Carnitine 6g"
            }, 
            {
                "arm_group_label": "Carnitine Medium", 
                "arm_group_type": "Experimental", 
                "description": "Levo-Carnitine 12 g"
            }, 
            {
                "arm_group_label": "Carnitine High", 
                "arm_group_type": "Experimental", 
                "description": "Levo-Carnitine 18 g"
            }
        ], 
        "brief_summary": {
            "textblock": "Prior work has shown that exogenous L-carnitine administration enhances glucose and lactate\n      oxidation, attenuates fatty acid toxicity, and improves endothelial-smooth muscle coupling\n      and cardiac mechanical efficiency.  The overall goal of this proposal is to investigate\n      L-carnitine as a novel adjunctive treatment of septic shock. In this study the investigators\n      will test our primary hypothesis: Early adjunctive L-carnitine administration in vasopressor\n      dependent septic shock will significantly reduce cumulative organ failure at 48 hours with\n      an associated decrease in 28-day mortality suggesting the need for further phase III study.\n      To accomplish this the investigators will conduct a phase II, double blinded, placebo\n      controlled, adaptive randomized trial of 250 eligible patients with vasopressor-dependent\n      septic shock. Study subjects will be assigned to one of four arms: low (6g), medium (12g) or\n      high (18g) dose intravenous L-carnitine or placebo for 12 hours as a part of early\n      resuscitative care."
        }, 
        "brief_title": "Rapid Administration of Carnitine in sEpsis", 
        "completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Septic Shock", 
        "condition_browse": {
            "mesh_term": [
                "Shock", 
                "Shock, Septic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Suspected or confirmed infection (examples include but are not limited to: white\n             cells in a normally sterile body fluid; perforated viscus; radiographic evidence of\n             pneumonia in clinical symptoms; a syndrome associated with a high risk of infection\n             e.g. cellulitis, cutaneous abscess, ascending cholangitis, toxic shock syndrome,\n             fever of unknown origin with high suspicion of infectious etiology)\n\n          2. Any two of four criteria of systemic inflammatory response as defined by the 2001\n             ACCP/SCCM Consensus Conference Committee;\n\n          3. Recognition of septic shock and initiation of quantitative resuscitation within 24\n             hours of enrollment;\n\n          4. Requirement of high dose vasopressors for \u22654 hours to treat shock: Norepinephrine >\n             0.05mcg/kg/min; dopamine >10mcg/kg/min; Phenylephrine >0.4 mcg/kg/min; epinephrine >\n             0.05 mcg/kg/min;\n\n          5. Cumulative sequential organ failure assessment (SOFA) score of \u2265 6;\n\n          6. Blood lactate level of >2.0 mMol/L.\n\n        Exclusion Criteria:\n\n          1. Age <18 years;\n\n          2. Pregnancy or breastfeeding;\n\n          3. Any primary diagnosis other than sepsis;\n\n          4. Established Do Not Resuscitate status or advanced directives restricting aggressive\n             care or treating physician deems aggressive care unsuitable;\n\n          5. Any history of seizures or a known seizure disorder;\n\n          6. Any known inborn error of metabolism;\n\n          7. Anticipated requirement for surgery that would interfere with the 12 hour infusion\n             time;\n\n          8. Active participation in another interventional study;\n\n          9. Cardiopulmonary resuscitation (chest compression or defibrillation) prior to\n             enrollment;\n\n         10. Known systemic allergy to L-carnitine.\n\n         11. Severe immunocompromised state (e.g. subject has neutropenia [receiving cytotoxic\n             chemotherapy with absolute neutrophil count <500/uL or expected to decline to < 500\n             uL within the next three days)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01665092", 
            "org_study_id": "GM103799"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Carnitine Low", 
                    "Carnitine Medium", 
                    "Carnitine High"
                ], 
                "intervention_name": "Levo-Carnitine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Control", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Carnitine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "February 26, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Henry Wang, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "University of Alabama Birmingham"
                }, 
                "investigator": {
                    "last_name": "Henry Wang, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jeffrey Green, MD"
                }, 
                "contact_backup": {
                    "last_name": "Deb Diercks, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Univeristy of California Davis"
                }, 
                "investigator": {
                    "last_name": "Jeffrey Green, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ryan Aronold, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Wilmington", 
                        "country": "United States", 
                        "state": "Delaware"
                    }, 
                    "name": "Christiana Care Health Services"
                }, 
                "investigator": {
                    "last_name": "Ryan Arnold, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mark Courtney, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "Northwestern University"
                }, 
                "investigator": {
                    "last_name": "Mark Courtney, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jeffrey Kline, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana"
                    }, 
                    "name": "Indiana University"
                }, 
                "investigator": {
                    "last_name": "Jeffrey Kline, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nathan Shapiro, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "BIDMC"
                }, 
                "investigator": {
                    "last_name": "Nathan Shapiro, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Rob Sherwin, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Wayne State University"
                }, 
                "investigator": {
                    "last_name": "Rob Sherwin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "aejones@umc.edu", 
                    "last_name": "Alan Jones, MD", 
                    "phone": "601-984-5443"
                }, 
                "facility": {
                    "address": {
                        "city": "Jackson", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "29316"
                    }, 
                    "name": "University of Mississippi Medical Center"
                }, 
                "investigator": {
                    "last_name": "Alan Jones, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Stephen Trzeciak, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Camden", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Cooper University Hospital"
                }, 
                "investigator": {
                    "last_name": "Stephen Trzeciak, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mike Runyon, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "Carolinas Medical Center"
                }, 
                "investigator": {
                    "last_name": "Mike Runyon, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Phase 2 Study of Levo-Carnitine for Vasopressor Dependent Septic Shock", 
        "overall_contact": {
            "email": "aejones@umc.edu", 
            "last_name": "Alan Jones, MD", 
            "phone": "601-984-5571"
        }, 
        "overall_official": {
            "affiliation": "University of Mississippi Medical Center", 
            "last_name": "Alan Jones, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "delta SOFA", 
            "safety_issue": "No", 
            "time_frame": "48 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01665092"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Mississippi Medical Center", 
            "investigator_full_name": "Alan Jones", 
            "investigator_title": "Professor of Emergency Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Mortality", 
            "safety_issue": "No", 
            "time_frame": "28 day"
        }, 
        "source": "University of Mississippi Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of General Medical Sciences (NIGMS)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Mississippi Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}